В первом полугодии 2016 года производство медизделий выросло на 13%
22 July 2016
Согласно отчету Росстата, в январе – июне 2016 года отечественные промышленники выпустили медицинской продукции на 15,8 млрд рублей, что на 13,3% больше, чем за аналогичный период 2015 года.
European Pharma and the Unified Patent Court
21 July 2016
One of the latest efforts to bring greater commonality in the European Union (EU) is the introduction of a European patent supported by a Unified Patent Court (UPC). Naturally the pharmaceutical industry will have a significant interest in improvements to the patent system in Europe; after all patents play an important role in ensuring that returns are made on significant research and development investment. So much so, that some say that protection of intellectual property is at the core of the business.
Biomedicine The White House Is Pushing Precision Medicine, but It Won’t Happen for Years
20 July 2016
With the right technologies to collect and make sense of biomedical information, we could speed up the pace of discoveries that lead to a new class of tailor-made drugs. That’s the argument behind the White House’s push for “precision medicine” (see “A Shot in the Arm for Obama’s Precision Medicine Initiative”).
Value-based care necessitates big changes for pharma marketers, says digital pharma agency
20 July 2016
Much has been discussed, and some dismissed, when it comes to value-based care in the pharma industry. However, no one can deny that the shift to outcomes-based healthcare is a sea change that will affect big pharma significantly.
Which big biopharma companies put R&D as their top priority?
19 July 2016
We love charts at Endpoints. They’re a great way to offer a snapshot of the data that highlight a dramatic comparison for readers. So we were delighted when one of our readers came up with two new charts from last week’s special report on the top 15 R&D budgets in biopharma.
Top R&D innovators in med tech
19 July 2016
Devicemakers didn’t hold back when it came to R&D in 2015. The industry’s top companies spent a total of $11.670 billion developing new devices and diagnostics last year, an 8% increase from 2014.
Q2 venture investing slows a tad, but the big money still flows into biotech
19 July 2016
Venture investing in biotech during the second quarter slowed somewhat from the blistering pace set in 2015, but the field still racked up another $1.7 billion, easily surpassing the mark for previous years and leaving 2016 on track to richly support the big new wave of drug developers in or near the clinic.
Russian pharma companies eye international expansion
18 July 2016
Russian pharmaceutical companies are trying to attract foreign consumers with their high quality and reasonably-priced medicines. But first they need to strengthen their positions on the domestic market, which is still dominated by foreign companies.
Biotech VC: On track for second-highest year in 2016
18 July 2016
The stock market pullback and lackluster IPO market have weighed on biotech venture financing--but only a bit. The sector is still on track for its second-highest venture financing total ever, behind last year’s sums. That’s according to the latest data through the first half of this year from PricewaterhouseCoopers and the National Venture Capital Association.
Health spending in U.S. to rise 5.8 percent a year through 2025: CMS
18 July 2016
Healthcare spending in the United States will likely grow by an average 5.8 percent per year over the next decade, a bit faster than the past two years, due to an aging population, rising medical prices and faster economic growth, according to updated projections from the federal government released on Wednesday.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024